Esperion Therapeutics Inc (ESPR)
Gross Profit Growth
36.09%
Quarterly · Period ending:
ESPR Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported36.09%period ending
Latest reported36.09%period ending
ESPR Quarterly Gross Profit YoY % (-76.71% → 36.09%)
Year-over-year change
High-resolution chart · PNG
ESPR gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 36.0881% | |
| 223.3338% | |
| -7.1537% | |
| -7.5277% | |
| -73.7921% | |
| 109.0682% | |
| 66.7929% | |
| 206.4474% | |
| 907.0206% | |
| 41.8884% | |
| 65.0794% | |
| 96.5856% | |
| 8.2487% | |
| 41.9524% | |
| 40.9332% | |
| -75.128% | |
| 89.0701% | |
| 29.8868% | |
| 148.7634% | |
| -81.6563% | |
| 242.3991% | |
| 121.3411% | |
| 107.5222% | |
| 606.7167% | |
| -98.1748% | |
| -127.5939% | |
| -13.836% | |
| -5.7737% | |
| 342.0884% | |
| 191.4622% | |
| 100% | |
| 100% | |
| -100% | |
| 100% | |
| -73.1308% | |
| -76.7082% |